Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy of low-dose radiotherapy (LDRT)
combined with durvalumab, etoposide, and cisplatin/carboplatin in the first-line treatment of
extensive-stage small cell lung cancer.